icad (ICAD) Stock Price, News & Analysis

Company Overview

iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.

Key Stats

• Today's Range: $3.87 to $3.87
• 50-Day Range: $3.65 to $3.95
• 52-Week Range: $1.19 to $4.02
• Volume: N/A
• Average Volume: 426,282 shs
• Market Capitalization: $106.31 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Hold

ICAD Stock Analysis - Frequently Asked Questions

How were icad's earnings last quarter?

icad inc. (NASDAQ:ICAD) released its quarterly earnings results on Tuesday, May, 13th. The technology company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.04. The technology company had revenue of $4.87 million for the quarter, compared to the consensus estimate of $4.54 million. icad had a negative net margin of 26.63% and a negative trailing twelve-month return on equity of 15.03%.

Who are icad's major shareholders?

icad's top institutional investors include Meteora Capital LLC (2.59%), OMERS ADMINISTRATION Corp (2.30%), First Eagle Investment Management LLC (2.11%) and Credit Industriel ET Commercial (1.64%). Insiders that own company stock include Jonathan Go and Dana R Brown.
View institutional ownership trends.

What other stocks do shareholders of icad own?

Based on aggregate information from My MarketBeat watchlists, some other companies that icad investors own include Enovix (ENVX), Globant (GLOB), Rambus (RMBS), Luminar Technologies (LAZR), Toast (TOST), COMPASS Pathways (CMPS) and Ginkgo Bioworks (DNA).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 9/08/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: COMP - SOFTWARE
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:ICAD
• CIK: 749660
• Web: www.icadmed.com
• Phone: (603) 882-5200
• Fax: 603-880-3843
• Employees: 140
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$5.62 million
• Net Margins: -26.63%
• Pretax Margin: -26.28%
• Return on Equity: -15.03%
• Return on Assets: -11.77%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.66
• Quick Ratio: 3.57

Sales & Book Value

• Annual Sales: $19.61 million
• Price / Sales: 5.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.08 per share
• Price / Book: 3.58

Miscellaneous

• Outstanding Shares: 27,470,000
• Free Float: 24,644,000
• Market Cap: $106.31 million
• Optionable: Optionable
• Beta: 1.37